Stay updated on SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial
Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.

Latest updates to the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page
- Check6 days agoChange DetectedThe page version was updated from v3.6.5 to v3.6.6, indicating a backend or UI maintenance release. This upgrade does not alter the study content or reported data and is intended for system improvements.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4. This signals a newer site revision or template update.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating an internal platform update; no visible changes to study details or layout are indicated by the changes provided.SummaryDifference0.0%

- Check63 days agoChange DetectedA new revision tag, v3.6.3, was added to the page, replacing the previous v3.6.2. This indicates an updated version of the study record.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page revision tag changed from v3.6.0 to v3.6.2, indicating a version update of the study record. No substantive study content or user-facing details were modified.SummaryDifference0.0%

- Check85 days agoChange DetectedThe page adds a recruitment status note signaling that participants are no longer being sought, and adds new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Intervention/Treatment heading formatting and the site revision label to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.